nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—Sulfacetamide—Sulfadiazine—malaria	0.229	0.608	CrCrCtD
Gliclazide—Sulfacetamide—Dapsone—malaria	0.147	0.392	CrCrCtD
Gliclazide—CYP2C19—Artemether—malaria	0.0531	0.127	CbGbCtD
Gliclazide—CYP2C9—Sulfadiazine—malaria	0.0519	0.124	CbGbCtD
Gliclazide—CYP2C9—Pyrimethamine—malaria	0.0519	0.124	CbGbCtD
Gliclazide—CYP2C19—Proguanil—malaria	0.0499	0.119	CbGbCtD
Gliclazide—CYP2C9—Artemether—malaria	0.0442	0.105	CbGbCtD
Gliclazide—CYP2C9—Proguanil—malaria	0.0415	0.0989	CbGbCtD
Gliclazide—CYP2C19—Quinine—malaria	0.0322	0.0767	CbGbCtD
Gliclazide—CYP2C9—Quinine—malaria	0.0268	0.0637	CbGbCtD
Gliclazide—CYP2C19—Dapsone—malaria	0.0244	0.0581	CbGbCtD
Gliclazide—CYP2C9—Quinidine—malaria	0.0235	0.056	CbGbCtD
Gliclazide—CYP2C9—Dapsone—malaria	0.0203	0.0483	CbGbCtD
Gliclazide—VEGFA—VEGF binds to VEGFR leading to receptor dimerization—KDR—malaria	0.00179	0.0449	CbGpPWpGaD
Gliclazide—VEGFA—VEGF and VEGFR signaling network—KDR—malaria	0.0015	0.0375	CbGpPWpGaD
Gliclazide—ABCC8—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.00148	0.0371	CbGpPWpGaD
Gliclazide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.00143	0.036	CbGpPWpGaD
Gliclazide—ALB—Scavenging of heme from plasma—HBB—malaria	0.00142	0.0356	CbGpPWpGaD
Gliclazide—KCNJ11—hematopoietic system—malaria	0.00139	0.102	CbGeAlD
Gliclazide—CYP2C19—blood plasma—malaria	0.00133	0.0983	CbGeAlD
Gliclazide—ALB—Scavenging of heme from plasma—HP—malaria	0.00131	0.0328	CbGpPWpGaD
Gliclazide—VEGFA—bone marrow—malaria	0.00124	0.0917	CbGeAlD
Gliclazide—VEGFA—Hypertrophy Model—IL18—malaria	0.00107	0.0268	CbGpPWpGaD
Gliclazide—ABCC8—kidney—malaria	0.00105	0.0773	CbGeAlD
Gliclazide—CYP2C9—blood plasma—malaria	0.00103	0.0762	CbGeAlD
Gliclazide—VEGFA—liver—malaria	0.00101	0.0741	CbGeAlD
Gliclazide—VEGFA—S1P1 pathway—KDR—malaria	0.000895	0.0225	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000886	0.0222	CbGpPWpGaD
Gliclazide—VEGFA—brain—malaria	0.000798	0.0588	CbGeAlD
Gliclazide—ABCC8—Integration of energy metabolism—PKLR—malaria	0.000743	0.0186	CbGpPWpGaD
Gliclazide—VEGFA—Angiogenesis—KDR—malaria	0.000743	0.0186	CbGpPWpGaD
Gliclazide—CYP2C19—hematopoietic system—malaria	0.000737	0.0543	CbGeAlD
Gliclazide—KCNJ11—Integration of energy metabolism—PKLR—malaria	0.00072	0.0181	CbGpPWpGaD
Gliclazide—ALB—HDL-mediated lipid transport—SCARB1—malaria	0.000704	0.0177	CbGpPWpGaD
Gliclazide—VEGFA—Alpha9 beta1 integrin signaling events—NOS2—malaria	0.000684	0.0171	CbGpPWpGaD
Gliclazide—VEGFA—Hypertrophy Model—IFNG—malaria	0.000627	0.0157	CbGpPWpGaD
Gliclazide—CYP2C9—hematopoietic system—malaria	0.000572	0.0421	CbGeAlD
Gliclazide—KCNJ11—brain—malaria	0.000571	0.0421	CbGeAlD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBB—malaria	0.000566	0.0142	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—KDR—malaria	0.000562	0.0141	CbGpPWpGaD
Gliclazide—VEGFA—HIF-2-alpha transcription factor network—KDR—malaria	0.000562	0.0141	CbGpPWpGaD
Gliclazide—VEGFA—EPHA-mediated growth cone collapse—KDR—malaria	0.000562	0.0141	CbGpPWpGaD
Gliclazide—ABCC8—brain—malaria	0.000526	0.0388	CbGeAlD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—malaria	0.000522	0.0131	CbGpPWpGaD
Gliclazide—CYP2C19—digestive system—malaria	0.000513	0.0378	CbGeAlD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—CD36—malaria	0.000511	0.0128	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—KDR—malaria	0.000493	0.0124	CbGpPWpGaD
Gliclazide—CYP2C19—blood—malaria	0.000488	0.036	CbGeAlD
Gliclazide—VEGFA—Allograft Rejection—IL12B—malaria	0.000486	0.0122	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—PKLR—malaria	0.000477	0.012	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—HBB—malaria	0.000475	0.0119	CbGpPWpGaD
Gliclazide—ALB—liver—malaria	0.000474	0.035	CbGeAlD
Gliclazide—VEGFA—Beta3 integrin cell surface interactions—KDR—malaria	0.000466	0.0117	CbGpPWpGaD
Gliclazide—ALB—Lipoprotein metabolism—SCARB1—malaria	0.000404	0.0101	CbGpPWpGaD
Gliclazide—KCNJ11—Type II diabetes mellitus—TNF—malaria	0.000399	0.01	CbGpPWpGaD
Gliclazide—CYP2C9—digestive system—malaria	0.000397	0.0293	CbGeAlD
Gliclazide—ALB—Folate Metabolism—HBB—malaria	0.000387	0.0097	CbGpPWpGaD
Gliclazide—CYP2C19—liver—malaria	0.000382	0.0282	CbGeAlD
Gliclazide—CYP2C9—blood—malaria	0.000379	0.0279	CbGeAlD
Gliclazide—ALB—brain—malaria	0.000376	0.0277	CbGeAlD
Gliclazide—VEGFA—SHP2 signaling—KDR—malaria	0.000367	0.0092	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL10—malaria	0.000355	0.00891	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—CD40LG—malaria	0.000355	0.00891	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL4—malaria	0.000346	0.00867	CbGpPWpGaD
Gliclazide—VEGFA—Integrins in angiogenesis—KDR—malaria	0.000343	0.00861	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—HLA-B—malaria	0.000338	0.00848	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—CD36—malaria	0.000328	0.00823	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—KDR—malaria	0.000323	0.0081	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—FAS—malaria	0.000318	0.00799	CbGpPWpGaD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCARB1—malaria	0.000315	0.0079	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—NOS2—malaria	0.000314	0.00789	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.000312	0.00784	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—HBB—malaria	0.000307	0.00771	CbGpPWpGaD
Gliclazide—CYP2C9—liver—malaria	0.000296	0.0218	CbGeAlD
Gliclazide—Erythema multiforme—Quinine—malaria	0.000288	0.00191	CcSEcCtD
Gliclazide—Agranulocytosis—Quinidine barbiturate—malaria	0.000286	0.0019	CcSEcCtD
Gliclazide—Eye disorder—Quinidine—malaria	0.000285	0.00189	CcSEcCtD
Gliclazide—Eye disorder—Quinine—malaria	0.000285	0.00189	CcSEcCtD
Gliclazide—Tinnitus—Quinidine—malaria	0.000284	0.00188	CcSEcCtD
Gliclazide—Tinnitus—Quinine—malaria	0.000284	0.00188	CcSEcCtD
Gliclazide—Vomiting—Proguanil—malaria	0.000284	0.00188	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000284	0.00712	CbGpPWpGaD
Gliclazide—Flushing—Quinidine—malaria	0.000283	0.00188	CcSEcCtD
Gliclazide—Flushing—Quinine—malaria	0.000283	0.00188	CcSEcCtD
Gliclazide—Rash—Proguanil—malaria	0.000282	0.00187	CcSEcCtD
Gliclazide—Dermatitis—Proguanil—malaria	0.000281	0.00186	CcSEcCtD
Gliclazide—Bradycardia—Quinidine barbiturate—malaria	0.00028	0.00186	CcSEcCtD
Gliclazide—Headache—Proguanil—malaria	0.00028	0.00185	CcSEcCtD
Gliclazide—Erythema—Dapsone—malaria	0.00028	0.00185	CcSEcCtD
Gliclazide—Hepatitis—Quinidine barbiturate—malaria	0.000275	0.00182	CcSEcCtD
Gliclazide—Hepatitis—Pentoxifylline—malaria	0.000275	0.00182	CcSEcCtD
Gliclazide—Chills—Quinidine—malaria	0.000274	0.00181	CcSEcCtD
Gliclazide—Chills—Quinine—malaria	0.000274	0.00181	CcSEcCtD
Gliclazide—Erythema—Clindamycin—malaria	0.000271	0.00179	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00027	0.00179	CcSEcCtD
Gliclazide—ALB—Lipid and lipoprotein metabolism—SCARB1—malaria	0.000269	0.00674	CbGpPWpGaD
Gliclazide—Insomnia—Sulfadiazine—malaria	0.000268	0.00178	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IFNG—malaria	0.000267	0.00671	CbGpPWpGaD
Gliclazide—Mental disorder—Quinidine—malaria	0.000267	0.00177	CcSEcCtD
Gliclazide—Mental disorder—Quinine—malaria	0.000267	0.00177	CcSEcCtD
Gliclazide—Flatulence—Clindamycin—malaria	0.000267	0.00177	CcSEcCtD
Gliclazide—Malnutrition—Quinine—malaria	0.000265	0.00176	CcSEcCtD
Gliclazide—Malnutrition—Quinidine—malaria	0.000265	0.00176	CcSEcCtD
Gliclazide—Erythema—Quinine—malaria	0.000265	0.00176	CcSEcCtD
Gliclazide—Erythema—Quinidine—malaria	0.000265	0.00176	CcSEcCtD
Gliclazide—Nausea—Proguanil—malaria	0.000265	0.00176	CcSEcCtD
Gliclazide—Visual impairment—Quinidine barbiturate—malaria	0.000265	0.00176	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—SCARB1—malaria	0.000264	0.00663	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—HPGDS—malaria	0.000263	0.00659	CbGpPWpGaD
Gliclazide—Back pain—Clindamycin—malaria	0.000262	0.00173	CcSEcCtD
Gliclazide—Erythema multiforme—Quinidine barbiturate—malaria	0.00026	0.00172	CcSEcCtD
Gliclazide—Eye disorder—Quinidine barbiturate—malaria	0.000257	0.0017	CcSEcCtD
Gliclazide—Tinnitus—Quinidine barbiturate—malaria	0.000257	0.0017	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000256	0.0017	CcSEcCtD
Gliclazide—Flushing—Quinidine barbiturate—malaria	0.000255	0.00169	CcSEcCtD
Gliclazide—Flushing—Pentoxifylline—malaria	0.000255	0.00169	CcSEcCtD
Gliclazide—Anaemia—Clindamycin—malaria	0.00025	0.00166	CcSEcCtD
Gliclazide—VEGFA—EPH-Ephrin signaling—KDR—malaria	0.000249	0.00625	CbGpPWpGaD
Gliclazide—Tremor—Quinine—malaria	0.000249	0.00165	CcSEcCtD
Gliclazide—Tremor—Quinidine—malaria	0.000249	0.00165	CcSEcCtD
Gliclazide—Chills—Quinidine barbiturate—malaria	0.000247	0.00164	CcSEcCtD
Gliclazide—Arrhythmia—Pentoxifylline—malaria	0.000245	0.00163	CcSEcCtD
Gliclazide—Cough—Dapsone—malaria	0.000244	0.00162	CcSEcCtD
Gliclazide—Agitation—Quinine—malaria	0.000244	0.00162	CcSEcCtD
Gliclazide—Agitation—Quinidine—malaria	0.000244	0.00162	CcSEcCtD
Gliclazide—Angioedema—Quinidine—malaria	0.000242	0.00161	CcSEcCtD
Gliclazide—Angioedema—Quinine—malaria	0.000242	0.00161	CcSEcCtD
Gliclazide—Gastrointestinal pain—Sulfadiazine—malaria	0.000242	0.00161	CcSEcCtD
Gliclazide—Leukopenia—Clindamycin—malaria	0.000242	0.0016	CcSEcCtD
Gliclazide—Mental disorder—Quinidine barbiturate—malaria	0.000241	0.0016	CcSEcCtD
Gliclazide—Erythema—Quinidine barbiturate—malaria	0.000239	0.00159	CcSEcCtD
Gliclazide—Malnutrition—Quinidine barbiturate—malaria	0.000239	0.00159	CcSEcCtD
Gliclazide—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000239	0.00601	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC4A1—malaria	0.000239	0.006	CbGpPWpGaD
Gliclazide—Erythema—Pentoxifylline—malaria	0.000239	0.00158	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IL2—malaria	0.000238	0.00596	CbGpPWpGaD
Gliclazide—Leukopenia—Quinidine—malaria	0.000238	0.00157	CcSEcCtD
Gliclazide—Leukopenia—Quinine—malaria	0.000238	0.00157	CcSEcCtD
Gliclazide—Flatulence—Pentoxifylline—malaria	0.000236	0.00156	CcSEcCtD
Gliclazide—Urticaria—Sulfadiazine—malaria	0.000236	0.00156	CcSEcCtD
Gliclazide—Tension—Quinidine barbiturate—malaria	0.000235	0.00156	CcSEcCtD
Gliclazide—Tension—Pentoxifylline—malaria	0.000235	0.00155	CcSEcCtD
Gliclazide—Palpitations—Quinidine—malaria	0.000235	0.00155	CcSEcCtD
Gliclazide—Palpitations—Quinine—malaria	0.000235	0.00155	CcSEcCtD
Gliclazide—Abdominal pain—Sulfadiazine—malaria	0.000234	0.00155	CcSEcCtD
Gliclazide—Body temperature increased—Sulfadiazine—malaria	0.000234	0.00155	CcSEcCtD
Gliclazide—Hypertension—Clindamycin—malaria	0.000234	0.00155	CcSEcCtD
Gliclazide—Loss of consciousness—Quinidine—malaria	0.000233	0.00155	CcSEcCtD
Gliclazide—Loss of consciousness—Quinine—malaria	0.000233	0.00155	CcSEcCtD
Gliclazide—Nervousness—Quinidine barbiturate—malaria	0.000233	0.00154	CcSEcCtD
Gliclazide—Nervousness—Pentoxifylline—malaria	0.000232	0.00154	CcSEcCtD
Gliclazide—Back pain—Pentoxifylline—malaria	0.000231	0.00153	CcSEcCtD
Gliclazide—Convulsion—Quinine—malaria	0.00023	0.00152	CcSEcCtD
Gliclazide—Convulsion—Quinidine—malaria	0.00023	0.00152	CcSEcCtD
Gliclazide—Discomfort—Clindamycin—malaria	0.000228	0.00151	CcSEcCtD
Gliclazide—Chest pain—Quinidine—malaria	0.000226	0.0015	CcSEcCtD
Gliclazide—Myalgia—Quinidine—malaria	0.000226	0.0015	CcSEcCtD
Gliclazide—Chest pain—Quinine—malaria	0.000226	0.0015	CcSEcCtD
Gliclazide—Myalgia—Quinine—malaria	0.000226	0.0015	CcSEcCtD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—KDR—malaria	0.000225	0.00563	CbGpPWpGaD
Gliclazide—Tremor—Quinidine barbiturate—malaria	0.000224	0.00149	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000224	0.00149	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000224	0.00149	CcSEcCtD
Gliclazide—Tremor—Pentoxifylline—malaria	0.000224	0.00148	CcSEcCtD
Gliclazide—Tachycardia—Dapsone—malaria	0.000223	0.00148	CcSEcCtD
Gliclazide—Ill-defined disorder—Pentoxifylline—malaria	0.000222	0.00147	CcSEcCtD
Gliclazide—Anaemia—Pentoxifylline—malaria	0.000221	0.00146	CcSEcCtD
Gliclazide—Agitation—Quinidine barbiturate—malaria	0.00022	0.00146	CcSEcCtD
Gliclazide—Agitation—Pentoxifylline—malaria	0.00022	0.00146	CcSEcCtD
Gliclazide—Angioedema—Quinidine barbiturate—malaria	0.000219	0.00145	CcSEcCtD
Gliclazide—Angioedema—Pentoxifylline—malaria	0.000218	0.00145	CcSEcCtD
Gliclazide—Hypersensitivity—Sulfadiazine—malaria	0.000218	0.00145	CcSEcCtD
Gliclazide—Confusional state—Quinidine—malaria	0.000218	0.00145	CcSEcCtD
Gliclazide—Confusional state—Quinine—malaria	0.000218	0.00145	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—DHFR—malaria	0.000217	0.00545	CbGpPWpGaD
Gliclazide—Thrombocytopenia—Clindamycin—malaria	0.000216	0.00143	CcSEcCtD
Gliclazide—Malaise—Pentoxifylline—malaria	0.000216	0.00143	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—SCARB1—malaria	0.000215	0.0054	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—HBB—malaria	0.000215	0.00539	CbGpPWpGaD
Gliclazide—Leukopenia—Quinidine barbiturate—malaria	0.000214	0.00142	CcSEcCtD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—IL6—malaria	0.000214	0.00537	CbGpPWpGaD
Gliclazide—Leukopenia—Pentoxifylline—malaria	0.000214	0.00142	CcSEcCtD
Gliclazide—Nervous system disorder—Quinidine—malaria	0.000212	0.00141	CcSEcCtD
Gliclazide—Nervous system disorder—Quinine—malaria	0.000212	0.00141	CcSEcCtD
Gliclazide—Thrombocytopenia—Quinidine—malaria	0.000212	0.00141	CcSEcCtD
Gliclazide—Thrombocytopenia—Quinine—malaria	0.000212	0.00141	CcSEcCtD
Gliclazide—VEGFA—Signaling by VEGF—KDR—malaria	0.000212	0.00532	CbGpPWpGaD
Gliclazide—Palpitations—Quinidine barbiturate—malaria	0.000212	0.0014	CcSEcCtD
Gliclazide—Tachycardia—Quinidine—malaria	0.000211	0.0014	CcSEcCtD
Gliclazide—Tachycardia—Quinine—malaria	0.000211	0.0014	CcSEcCtD
Gliclazide—Palpitations—Pentoxifylline—malaria	0.000211	0.0014	CcSEcCtD
Gliclazide—Loss of consciousness—Quinidine barbiturate—malaria	0.00021	0.0014	CcSEcCtD
Gliclazide—Skin disorder—Quinidine—malaria	0.00021	0.00139	CcSEcCtD
Gliclazide—Skin disorder—Quinine—malaria	0.00021	0.00139	CcSEcCtD
Gliclazide—Pruritus—Sulfadiazine—malaria	0.00021	0.00139	CcSEcCtD
Gliclazide—Hyperhidrosis—Quinidine—malaria	0.000209	0.00139	CcSEcCtD
Gliclazide—Hyperhidrosis—Quinine—malaria	0.000209	0.00139	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IFNG—malaria	0.000209	0.00524	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—malaria	0.000208	0.00523	CbGpPWpGaD
Gliclazide—Convulsion—Quinidine barbiturate—malaria	0.000208	0.00138	CcSEcCtD
Gliclazide—Convulsion—Pentoxifylline—malaria	0.000207	0.00137	CcSEcCtD
Gliclazide—Insomnia—Dapsone—malaria	0.000206	0.00137	CcSEcCtD
Gliclazide—Hypertension—Pentoxifylline—malaria	0.000206	0.00137	CcSEcCtD
Gliclazide—Hypotension—Clindamycin—malaria	0.000206	0.00137	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL10—malaria	0.000206	0.00517	CbGpPWpGaD
Gliclazide—Myalgia—Quinidine barbiturate—malaria	0.000204	0.00135	CcSEcCtD
Gliclazide—Arthralgia—Quinidine barbiturate—malaria	0.000204	0.00135	CcSEcCtD
Gliclazide—Chest pain—Quinidine barbiturate—malaria	0.000204	0.00135	CcSEcCtD
Gliclazide—Chest pain—Pentoxifylline—malaria	0.000204	0.00135	CcSEcCtD
Gliclazide—Myalgia—Pentoxifylline—malaria	0.000204	0.00135	CcSEcCtD
Gliclazide—Anxiety—Quinidine barbiturate—malaria	0.000203	0.00135	CcSEcCtD
Gliclazide—Diarrhoea—Sulfadiazine—malaria	0.000203	0.00134	CcSEcCtD
Gliclazide—Anxiety—Pentoxifylline—malaria	0.000203	0.00134	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000202	0.00134	CcSEcCtD
Gliclazide—Hypotension—Quinine—malaria	0.000202	0.00134	CcSEcCtD
Gliclazide—Hypotension—Quinidine—malaria	0.000202	0.00134	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000202	0.00134	CcSEcCtD
Gliclazide—Discomfort—Pentoxifylline—malaria	0.000201	0.00133	CcSEcCtD
Gliclazide—Dry mouth—Pentoxifylline—malaria	0.000199	0.00132	CcSEcCtD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—malaria	0.000198	0.00496	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Quinine—malaria	0.000197	0.00131	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Quinidine—malaria	0.000197	0.00131	CcSEcCtD
Gliclazide—Confusional state—Quinidine barbiturate—malaria	0.000197	0.00131	CcSEcCtD
Gliclazide—Dyspnoea—Clindamycin—malaria	0.000197	0.0013	CcSEcCtD
Gliclazide—Confusional state—Pentoxifylline—malaria	0.000197	0.0013	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—PKLR—malaria	0.000195	0.0049	CbGpPWpGaD
Gliclazide—Dyspepsia—Clindamycin—malaria	0.000194	0.00129	CcSEcCtD
Gliclazide—Infection—Pentoxifylline—malaria	0.000194	0.00128	CcSEcCtD
Gliclazide—Dyspnoea—Quinine—malaria	0.000193	0.00128	CcSEcCtD
Gliclazide—Dyspnoea—Quinidine—malaria	0.000193	0.00128	CcSEcCtD
Gliclazide—Nervous system disorder—Quinidine barbiturate—malaria	0.000192	0.00127	CcSEcCtD
Gliclazide—Thrombocytopenia—Quinidine barbiturate—malaria	0.000191	0.00127	CcSEcCtD
Gliclazide—Thrombocytopenia—Pentoxifylline—malaria	0.000191	0.00127	CcSEcCtD
Gliclazide—Tachycardia—Quinidine barbiturate—malaria	0.000191	0.00126	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Clindamycin—malaria	0.000191	0.00126	CcSEcCtD
Gliclazide—Tachycardia—Pentoxifylline—malaria	0.00019	0.00126	CcSEcCtD
Gliclazide—Fatigue—Clindamycin—malaria	0.00019	0.00126	CcSEcCtD
Gliclazide—Skin disorder—Quinidine barbiturate—malaria	0.00019	0.00126	CcSEcCtD
Gliclazide—Skin disorder—Pentoxifylline—malaria	0.00019	0.00126	CcSEcCtD
Gliclazide—Hyperhidrosis—Quinidine barbiturate—malaria	0.000189	0.00125	CcSEcCtD
Gliclazide—Pain—Clindamycin—malaria	0.000189	0.00125	CcSEcCtD
Gliclazide—Constipation—Clindamycin—malaria	0.000189	0.00125	CcSEcCtD
Gliclazide—Hyperhidrosis—Pentoxifylline—malaria	0.000189	0.00125	CcSEcCtD
Gliclazide—Vomiting—Sulfadiazine—malaria	0.000188	0.00125	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Quinidine—malaria	0.000187	0.00124	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Quinine—malaria	0.000187	0.00124	CcSEcCtD
Gliclazide—Rash—Sulfadiazine—malaria	0.000187	0.00124	CcSEcCtD
Gliclazide—Dermatitis—Sulfadiazine—malaria	0.000187	0.00124	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dapsone—malaria	0.000187	0.00124	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IL1B—malaria	0.000186	0.00467	CbGpPWpGaD
Gliclazide—Headache—Sulfadiazine—malaria	0.000186	0.00123	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—IL2—malaria	0.000186	0.00466	CbGpPWpGaD
Gliclazide—Hypotension—Quinidine barbiturate—malaria	0.000183	0.00121	CcSEcCtD
Gliclazide—Hypotension—Pentoxifylline—malaria	0.000182	0.00121	CcSEcCtD
Gliclazide—Gastrointestinal pain—Clindamycin—malaria	0.000181	0.0012	CcSEcCtD
Gliclazide—Abdominal pain—Dapsone—malaria	0.00018	0.0012	CcSEcCtD
Gliclazide—Body temperature increased—Dapsone—malaria	0.00018	0.0012	CcSEcCtD
Gliclazide—Feeling abnormal—Quinidine—malaria	0.000178	0.00118	CcSEcCtD
Gliclazide—Feeling abnormal—Quinine—malaria	0.000178	0.00118	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000178	0.00118	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000178	0.00118	CcSEcCtD
Gliclazide—Gastrointestinal pain—Quinidine—malaria	0.000177	0.00117	CcSEcCtD
Gliclazide—Gastrointestinal pain—Quinine—malaria	0.000177	0.00117	CcSEcCtD
Gliclazide—Insomnia—Pentoxifylline—malaria	0.000176	0.00117	CcSEcCtD
Gliclazide—Nausea—Sulfadiazine—malaria	0.000176	0.00117	CcSEcCtD
Gliclazide—Urticaria—Clindamycin—malaria	0.000175	0.00116	CcSEcCtD
Gliclazide—Abdominal pain—Clindamycin—malaria	0.000175	0.00116	CcSEcCtD
Gliclazide—Body temperature increased—Clindamycin—malaria	0.000175	0.00116	CcSEcCtD
Gliclazide—Dyspnoea—Quinidine barbiturate—malaria	0.000174	0.00116	CcSEcCtD
Gliclazide—Dyspnoea—Pentoxifylline—malaria	0.000174	0.00115	CcSEcCtD
Gliclazide—Somnolence—Quinidine barbiturate—malaria	0.000174	0.00115	CcSEcCtD
Gliclazide—Somnolence—Pentoxifylline—malaria	0.000173	0.00115	CcSEcCtD
Gliclazide—Urticaria—Quinidine—malaria	0.000172	0.00114	CcSEcCtD
Gliclazide—Urticaria—Quinine—malaria	0.000172	0.00114	CcSEcCtD
Gliclazide—Dyspepsia—Pentoxifylline—malaria	0.000172	0.00114	CcSEcCtD
Gliclazide—Abdominal pain—Quinidine—malaria	0.000171	0.00113	CcSEcCtD
Gliclazide—Body temperature increased—Quinidine—malaria	0.000171	0.00113	CcSEcCtD
Gliclazide—Abdominal pain—Quinine—malaria	0.000171	0.00113	CcSEcCtD
Gliclazide—Body temperature increased—Quinine—malaria	0.000171	0.00113	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—SCARB1—malaria	0.000171	0.00429	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000169	0.00112	CcSEcCtD
Gliclazide—Pain—Quinidine barbiturate—malaria	0.000167	0.00111	CcSEcCtD
Gliclazide—Constipation—Quinidine barbiturate—malaria	0.000167	0.00111	CcSEcCtD
Gliclazide—Constipation—Pentoxifylline—malaria	0.000167	0.00111	CcSEcCtD
Gliclazide—Hypersensitivity—Clindamycin—malaria	0.000163	0.00108	CcSEcCtD
Gliclazide—VEGFA—Differentiation Pathway—IL6—malaria	0.000163	0.00408	CbGpPWpGaD
Gliclazide—Feeling abnormal—Quinidine barbiturate—malaria	0.000161	0.00107	CcSEcCtD
Gliclazide—Feeling abnormal—Pentoxifylline—malaria	0.000161	0.00107	CcSEcCtD
Gliclazide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00016	0.00106	CcSEcCtD
Gliclazide—Hypersensitivity—Quinine—malaria	0.00016	0.00106	CcSEcCtD
Gliclazide—Hypersensitivity—Quinidine—malaria	0.00016	0.00106	CcSEcCtD
Gliclazide—Gastrointestinal pain—Pentoxifylline—malaria	0.00016	0.00106	CcSEcCtD
Gliclazide—Asthenia—Clindamycin—malaria	0.000158	0.00105	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000157	0.00394	CbGpPWpGaD
Gliclazide—Pruritus—Clindamycin—malaria	0.000156	0.00104	CcSEcCtD
Gliclazide—Asthenia—Quinine—malaria	0.000155	0.00103	CcSEcCtD
Gliclazide—Asthenia—Quinidine—malaria	0.000155	0.00103	CcSEcCtD
Gliclazide—Urticaria—Quinidine barbiturate—malaria	0.000155	0.00103	CcSEcCtD
Gliclazide—Urticaria—Pentoxifylline—malaria	0.000155	0.00103	CcSEcCtD
Gliclazide—Abdominal pain—Quinidine barbiturate—malaria	0.000155	0.00102	CcSEcCtD
Gliclazide—Body temperature increased—Quinidine barbiturate—malaria	0.000155	0.00102	CcSEcCtD
Gliclazide—Abdominal pain—Pentoxifylline—malaria	0.000154	0.00102	CcSEcCtD
Gliclazide—Body temperature increased—Pentoxifylline—malaria	0.000154	0.00102	CcSEcCtD
Gliclazide—Pruritus—Quinine—malaria	0.000153	0.00102	CcSEcCtD
Gliclazide—Pruritus—Quinidine—malaria	0.000153	0.00102	CcSEcCtD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000152	0.00381	CbGpPWpGaD
Gliclazide—Diarrhoea—Clindamycin—malaria	0.000151	0.001	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—CRP—malaria	0.00015	0.00375	CbGpPWpGaD
Gliclazide—Diarrhoea—Quinine—malaria	0.000148	0.000982	CcSEcCtD
Gliclazide—Diarrhoea—Quinidine—malaria	0.000148	0.000982	CcSEcCtD
Gliclazide—Dizziness—Clindamycin—malaria	0.000146	0.000968	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—CD36—malaria	0.000145	0.00365	CbGpPWpGaD
Gliclazide—Vomiting—Dapsone—malaria	0.000145	0.000962	CcSEcCtD
Gliclazide—Hypersensitivity—Quinidine barbiturate—malaria	0.000144	0.000955	CcSEcCtD
Gliclazide—Hypersensitivity—Pentoxifylline—malaria	0.000144	0.000953	CcSEcCtD
Gliclazide—Dizziness—Quinidine—malaria	0.000143	0.000949	CcSEcCtD
Gliclazide—Dizziness—Quinine—malaria	0.000143	0.000949	CcSEcCtD
Gliclazide—Headache—Dapsone—malaria	0.000143	0.000948	CcSEcCtD
Gliclazide—VEGFA—Focal Adhesion—KDR—malaria	0.000142	0.00356	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL4—malaria	0.000141	0.00353	CbGpPWpGaD
Gliclazide—Vomiting—Clindamycin—malaria	0.00014	0.00093	CcSEcCtD
Gliclazide—Asthenia—Quinidine barbiturate—malaria	0.00014	0.00093	CcSEcCtD
Gliclazide—Asthenia—Pentoxifylline—malaria	0.00014	0.000928	CcSEcCtD
Gliclazide—VEGFA—SHP2 signaling—IL6—malaria	0.00014	0.0035	CbGpPWpGaD
Gliclazide—Rash—Clindamycin—malaria	0.000139	0.000923	CcSEcCtD
Gliclazide—Dermatitis—Clindamycin—malaria	0.000139	0.000922	CcSEcCtD
Gliclazide—Headache—Clindamycin—malaria	0.000138	0.000917	CcSEcCtD
Gliclazide—Pruritus—Quinidine barbiturate—malaria	0.000138	0.000917	CcSEcCtD
Gliclazide—Pruritus—Pentoxifylline—malaria	0.000138	0.000915	CcSEcCtD
Gliclazide—Vomiting—Quinine—malaria	0.000138	0.000913	CcSEcCtD
Gliclazide—Vomiting—Quinidine—malaria	0.000138	0.000913	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—ICAM1—malaria	0.000137	0.00345	CbGpPWpGaD
Gliclazide—Rash—Quinine—malaria	0.000137	0.000905	CcSEcCtD
Gliclazide—Rash—Quinidine—malaria	0.000137	0.000905	CcSEcCtD
Gliclazide—Dermatitis—Quinidine—malaria	0.000136	0.000904	CcSEcCtD
Gliclazide—Dermatitis—Quinine—malaria	0.000136	0.000904	CcSEcCtD
Gliclazide—Headache—Quinidine—malaria	0.000136	0.000899	CcSEcCtD
Gliclazide—Headache—Quinine—malaria	0.000136	0.000899	CcSEcCtD
Gliclazide—Nausea—Dapsone—malaria	0.000136	0.000899	CcSEcCtD
Gliclazide—VEGFA—Allograft Rejection—TNF—malaria	0.000135	0.00339	CbGpPWpGaD
Gliclazide—Diarrhoea—Quinidine barbiturate—malaria	0.000134	0.000886	CcSEcCtD
Gliclazide—Diarrhoea—Pentoxifylline—malaria	0.000133	0.000885	CcSEcCtD
Gliclazide—ABCC8—Metabolism—DHODH—malaria	0.000132	0.00331	CbGpPWpGaD
Gliclazide—Nausea—Clindamycin—malaria	0.000131	0.000869	CcSEcCtD
Gliclazide—Dizziness—Quinidine barbiturate—malaria	0.000129	0.000857	CcSEcCtD
Gliclazide—Dizziness—Pentoxifylline—malaria	0.000129	0.000855	CcSEcCtD
Gliclazide—Nausea—Quinine—malaria	0.000129	0.000853	CcSEcCtD
Gliclazide—Nausea—Quinidine—malaria	0.000129	0.000853	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—DHODH—malaria	0.000128	0.00321	CbGpPWpGaD
Gliclazide—Vomiting—Quinidine barbiturate—malaria	0.000124	0.000824	CcSEcCtD
Gliclazide—Vomiting—Pentoxifylline—malaria	0.000124	0.000822	CcSEcCtD
Gliclazide—Rash—Quinidine barbiturate—malaria	0.000123	0.000817	CcSEcCtD
Gliclazide—Dermatitis—Quinidine barbiturate—malaria	0.000123	0.000816	CcSEcCtD
Gliclazide—Rash—Pentoxifylline—malaria	0.000123	0.000815	CcSEcCtD
Gliclazide—Dermatitis—Pentoxifylline—malaria	0.000123	0.000815	CcSEcCtD
Gliclazide—Headache—Quinidine barbiturate—malaria	0.000122	0.000812	CcSEcCtD
Gliclazide—Headache—Pentoxifylline—malaria	0.000122	0.00081	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—CRP—malaria	0.000122	0.00305	CbGpPWpGaD
Gliclazide—Nausea—Quinidine barbiturate—malaria	0.000116	0.00077	CcSEcCtD
Gliclazide—Nausea—Pentoxifylline—malaria	0.000116	0.000768	CcSEcCtD
Gliclazide—ALB—Platelet degranulation—CD36—malaria	0.000116	0.0029	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SLC4A1—malaria	0.000112	0.00281	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—ICAM1—malaria	0.000112	0.00281	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.00011	0.00277	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC4A1—malaria	0.000109	0.00273	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1B—malaria	0.000108	0.00271	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—DECR1—malaria	0.000105	0.00264	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IFNG—malaria	0.000105	0.00262	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—DECR1—malaria	0.000102	0.00256	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—HPGDS—malaria	9.77e-05	0.00245	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—CRP—malaria	9.67e-05	0.00243	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—HBB—malaria	9.53e-05	0.00239	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL1B—malaria	9.33e-05	0.00234	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—KDR—malaria	9.26e-05	0.00232	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HBB—malaria	9.24e-05	0.00232	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—HPGDS—malaria	8.91e-05	0.00224	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—ICAM1—malaria	8.89e-05	0.00223	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—IL6—malaria	8.56e-05	0.00215	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IFNG—malaria	8.51e-05	0.00214	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PKLR—malaria	8.5e-05	0.00213	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PKLR—malaria	8.24e-05	0.00207	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IL2—malaria	8.15e-05	0.00204	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—IL6—malaria	8.08e-05	0.00203	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—malaria	7.84e-05	0.00197	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	7.72e-05	0.00194	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CD36—malaria	7.64e-05	0.00192	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	7.63e-05	0.00191	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL1B—malaria	7.59e-05	0.0019	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—HBB—malaria	7.58e-05	0.0019	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—G6PD—malaria	7.57e-05	0.0019	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL2—malaria	7.56e-05	0.0019	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—CD36—malaria	7.5e-05	0.00188	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—G6PD—malaria	7.34e-05	0.00184	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—DECR1—malaria	6.85e-05	0.00172	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ACKR1—malaria	6.85e-05	0.00172	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—malaria	6.77e-05	0.0017	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IFNG—malaria	6.76e-05	0.0017	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—malaria	6.67e-05	0.00167	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—KDR—malaria	6.61e-05	0.00166	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—malaria	6.33e-05	0.00159	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	6.25e-05	0.00157	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS2—malaria	6.16e-05	0.00155	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—malaria	6.03e-05	0.00151	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—HPGDS—malaria	5.77e-05	0.00145	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HPGDS—malaria	5.6e-05	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TLR9—malaria	5.52e-05	0.00138	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—malaria	5.51e-05	0.00138	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—malaria	5.46e-05	0.00137	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—DHFR—malaria	5.36e-05	0.00134	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SCARB1—malaria	5.3e-05	0.00133	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—DHFR—malaria	5.2e-05	0.0013	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SCARB1—malaria	5.14e-05	0.00129	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CD36—malaria	5.13e-05	0.00129	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—malaria	4.45e-05	0.00112	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—malaria	4.38e-05	0.0011	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DHODH—malaria	4.25e-05	0.00107	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—malaria	4.2e-05	0.00105	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.18e-05	0.00105	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—malaria	4.16e-05	0.00104	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.84e-05	0.000963	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DHODH—malaria	3.82e-05	0.000957	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.75e-05	0.000942	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC4A1—malaria	3.61e-05	0.000907	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—malaria	3.53e-05	0.000886	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—malaria	3.53e-05	0.000885	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DHODH—malaria	3.48e-05	0.000873	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.45e-05	0.000864	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.42e-05	0.000859	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DECR1—malaria	3.4e-05	0.000853	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CD36—malaria	3.33e-05	0.000835	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC4A1—malaria	3.24e-05	0.000814	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CD36—malaria	3.23e-05	0.000809	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.14e-05	0.000788	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—malaria	3.12e-05	0.000782	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HBB—malaria	3.07e-05	0.000771	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DECR1—malaria	3.05e-05	0.000765	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC4A1—malaria	2.96e-05	0.000742	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—malaria	2.88e-05	0.000722	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DECR1—malaria	2.78e-05	0.000698	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HBB—malaria	2.76e-05	0.000692	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PKLR—malaria	2.74e-05	0.000687	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CD36—malaria	2.65e-05	0.000664	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—malaria	2.52e-05	0.000631	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HBB—malaria	2.52e-05	0.000631	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PKLR—malaria	2.46e-05	0.000617	CbGpPWpGaD
Gliclazide—ALB—Metabolism—G6PD—malaria	2.44e-05	0.000612	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	2.41e-05	0.000604	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PKLR—malaria	2.24e-05	0.000562	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KDR—malaria	2.2e-05	0.000551	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—G6PD—malaria	2.19e-05	0.00055	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—malaria	2.18e-05	0.000546	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	2.16e-05	0.000543	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—G6PD—malaria	2e-05	0.000501	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.97e-05	0.000495	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HPGDS—malaria	1.86e-05	0.000467	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DHFR—malaria	1.73e-05	0.000433	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SCARB1—malaria	1.71e-05	0.000429	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HPGDS—malaria	1.67e-05	0.000419	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DHFR—malaria	1.55e-05	0.000389	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SCARB1—malaria	1.53e-05	0.000385	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HPGDS—malaria	1.52e-05	0.000382	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—malaria	1.48e-05	0.000372	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—malaria	1.42e-05	0.000357	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DHFR—malaria	1.41e-05	0.000355	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SCARB1—malaria	1.4e-05	0.000351	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CD36—malaria	1.07e-05	0.000269	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CD36—malaria	9.63e-06	0.000242	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CD36—malaria	8.78e-06	0.00022	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—malaria	8.37e-06	0.00021	CbGpPWpGaD
